[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340750-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340750-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","overexpression-of-c1orf74-predicts-poor-outcome-and-promote-cervical-cancer-progression-research-article","Overexpression of C1orf74 predicts poor outcome and promote cervical cancer progression - Research article","","Cervical cancer remains a leading cause of morbidity and mortality, and improved biomarkers are urgently needed to clarify disease progression. Differentially expressed genes were screened in TCGA, identifying C1orf74 as markedly upregulated and linked to unfavorable prognosis. Higher C1orf74 expression correlated with clinical stage, T stage, histological type, and survival. Enrichment suggested involvement in MAPK signaling, with associations to multiple immune cell infiltrates. C1orf74 knockdown suppressed cervical cancer cell growth in vitro, indicating a role in tumor immune microenvironment and potential therapeutic value.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/overexpression-of-c1orf74-predicts-poor-outcome-and-promote-cervical-cancer-progression-research-article/340750/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/overexpression-of-c1orf74-predicts-poor-outcome-and-promote-cervical-cancer-progression-research-article/340750.png","ImageObject",300,407,{"name":42,"@type":43},"Theodora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was C1orf74 identified in the study?","Question",{"text":63,"@type":64},"Differentially expressed genes were screened using the Cancer Genome Atlas (TCGA), and C1orf74 was selected for further investigation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What clinical factors are associated with higher C1orf74 expression?",{"text":68,"@type":64},"Higher C1orf74 expression was significantly related to clinical stage, T stage, histological type, and survival status.",{"name":70,"@type":61,"acceptedAnswer":71},"What functional effects does C1orf74 knockdown have on cervical cancer cells?",{"text":72,"@type":64},"Knocking down C1orf74 significantly inhibited cervical cancer growth in vitro.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340750,1790146620,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Heliyon 10 (2024) e40966  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \n| Research article\u003Cbr>Overexpression of C1orf74 predicts poor outcome and promote cervical cancer progression\u003Cbr>Hai Zhu a, Yaping Wang a,b, Yu Zhang a, Yun Tiana,b, Duan Liu a, Xiabing Lia, Gaili Jib,c, Caixia Mab,c, Hongyu Li a,b,*\u003Cbr>a Gynecologic Oncology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China b Zhengzhou Key Laboratory of Gynecological Oncology, Zhengzhou, 450052, Henan, China\u003Cbr>c Department of Gynecology and Obstetrics, The Third Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords: C1orf74\u003Cbr>Cervical cancer Prognosis Immune infiltration\u003Cbr>Immune checkpoints |  | Cervical cancer (CC), which ranks among the four most common cancers in women, is a leading cause of both illness and death globally. It’s urgent to identify a new biomarker to elucidate the potential mechanisms underlying the progression of CC. Here, we screened the differentially expressed genes (DEGs) in the Cancer Genome Atlas database (TCGA) and selected Chromosome 1 open reading frame 74 (C1orf74) for further investigation. C1orf74 levels were elevated, indicating a link to poor prognosis.\u003Cbr>Higher expression of C1orf74 was significantly related to clinical stage, T stage, histological type and survival status. Functional enrichment analysis indicated that C1orf74 is likely associated with the MAPK signaling pathway. Moreover, we found that C1orf74 was correlated with multifarious immune cell infiltration. Finally, the knockdown of C1orf74 significantly inhibited the growth of CC in vitro. In conclusion, C1orf74 promotes CC proliferation and progression, is closely associated with poor prognosis, and plays a role in the tumor immune microenvironment. The research indicates that C1orf74 is important for treating CC and may help develop new strategies to improve patient outcomes. |\n\n1. Introduction  \nCervical cancer (CC) is a gynecological malignant tumor with the highest incidence in women of childbearing age [1]. According to 2020 global statistics, it is one of the most commonly diagnosed cancers among the four gynecological malignancies and the fourth major cause of cancer-related death in women [2]. Despite advancements in surgery, chemotherapy, and radiotherapy, the recurrence rate and metastasis rate of advanced cervical cancer remain high at 40.3 % and 31 %, respectively [3]. The median survival for patients with advanced cervical cancer is merely 8–13 months [4], and the prognosis remains be poor. Consequently, there is of great importance for explore effective predictive biomarkers and molecular mechanisms involved in the prognosis of cervical cancer, which may play a crucial role in the discovery of better predictive and therapeutic targets.  \nThe protein C1ORF74 encoded by the C1orf74 gene located in the chromosomal position of 1q32.2. It has been confirmed that C1orf74 is up-regulated in lung adenocarcinoma and the higher the expression, the worse the prognosis. High expression of C1orf74  \n* Corresponding author. Gynecologic Oncology, The Third Affiliated Hospital of Zhengzhou University, No. 7 Kangfu Front Street, Zhengzhou, Henan, 450000, China.  \nE-mail address: [lihongyu99@zzu.edu.cn](lihongyu99@zzu.edu.cn) (H. Li).  \n[https://doi.org/10.1016/j.heliyon.2024.e40966](https://doi.org/10.1016/j.heliyon.2024.e40966)  \nReceived 2 September 2024; Received in revised form 1 November 2024; Accepted 4 December 2024 Available online 9 December 2024  \n2405-8440/© 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC license ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)).  \nH. Zhu et al. Heliyon 10 (2024) e40966  \nFig. 1. Fl","cbCaitV5zU6aY5WV","https://ap.wps.com/l/cbCaitV5zU6aY5WV","pdf",18298600,18,"English","# Introduction\n# Materials and method\n## Data collection analysis","[{\"question\":\"How was C1orf74 identified in the study?\",\"answer\":\"Differentially expressed genes were screened using the Cancer Genome Atlas (TCGA), and C1orf74 was selected for further investigation.\"},{\"question\":\"What clinical factors are associated with higher C1orf74 expression?\",\"answer\":\"Higher C1orf74 expression was significantly related to clinical stage, T stage, histological type, and survival status.\"},{\"question\":\"What functional effects does C1orf74 knockdown have on cervical cancer cells?\",\"answer\":\"Knocking down C1orf74 significantly inhibited cervical cancer growth in vitro.\"}]","Overexpression of C1orf74 predicts poor outcome and promote cervical cancer progression - Research article | PDF",1790038685,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d88c9366ed87a0b2ea1ee37564639d0.webp",983,1341,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7bbc8627b30951113c41b6f0e4b7b47.webp",982,1340,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/378cef7cc156d5ccf7cb047a678de70d.webp",981,1338,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6b19386f91fec5524c393d7e6c31dcb.webp",980,1337]